 Orbax
 View other items in the same category as Orbax Product UsesOrbaxTM Tablets are indicated for the management of diseases in dogs and cats associated with bacteria susceptible to orbifloxacin. Orbax has been shown to be effective in skin and soft tissue infections (wounds and abscesses) in the dog and cat, and urinary tract infections (cystitis) in the dog, associated with bacteria susceptible to orbifloxacin. Product ContainsOrbifloxacin Dosage and AdministrationFor routine outpatient treatment of infection caused by a susceptible organism, in an otherwise healthy dog or cat, the dose of Orbax is 2.5 to 7.5 mg/kg of body weight administered once daily. For the treatment of skin and associated soft tissue infections, Orbax Tablets should be given for 2-3 days beyond the cessation of clinical signs to a maximum of 30 days. For the treatment of urinary tract infections, Orbax should be administered for at least 10 consecutive days. If no improvement is seen within 5 days, the diagnosis should be re-evaluated and a different course of therapy considered. Warnings, Side Effects and Drug InteractionsCompounds (eg, sucralfate, antacids, and multivitamins) containing divalent and trivalent cations (eg, iron, aluminum, calcium, magnesium, and zinc) may substantially interfere with the absorption of quinolones resulting in a decrease in effectiveness. Orbifloxacin and other quinolones have been shown to cause cartilage damage in immature animals of most species tested, the dog being particularly sensitive to this side effect. Orbifloxacin is contraindicated in immature dogs during the rapid growth phase (between 2 and 8 months of age in small and medium-sized breeds, and up to 18 months of age in large and giant breeds). Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders as, in rare instances, convulsive seizures have occurred. Quinolones have been shown to produce erosions of cartilage of weight-bearing joints and other signs of arthropathy in immature animals of various species. Safety in breeding or pregnant dogs and cats has not been established. Avoid contact with eyes. In case of contact, immediately flush eyes with copious amounts of water for 15 minutes. In case of dermal contact, wash skin with soap and water. Consult a physician if irritation persists following ocular or dermal exposure. Individuals with a history of hypersensitivity to quinolones should avoid this product. In humans, there is a risk of user photosensitization within a few hours after excessive exposure to quinolones. If excessive accidental exposure occurs, avoid direct sunlight. StorageStore between 2° and 30°C (36° and 86°F). Protect from excessive moisture. ManufacturerSchering-Plough Animal Health Registration StatusNADA #141-081, Approved by FDA Federal law restricts this drug to use by or on the order of a licensed veterinarian.
|
